CORC  > 暨南大学
Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome
Alnaggar, Mohammed[1,2,3]; Lin, Mao[4,5]; Mesmar, Adnan[6]; Liang, Shuzhen[5,6]; Qaid, Ammar[3]; Xu, Kecheng[3,4]; Chen, Jibing[5,6]; Niu, Lizhi[3,4,5]; Yin, Zhinan[1,2]
2018
卷号48期号:5页码:1882
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4313476
专题暨南大学
作者单位1.[1]Jinan Univ, Biomed Translat Res Inst, Guangzhou, Guangdong, Peoples R China
2.[2]Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
3.[3]Jinan Univ Sch, Fuda Canc Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China
4.[4]Jinan Univ Sch, Fuda Canc Hosp, Dept Biol Treatment Ctr, Guangzhou, Guangdong, Peoples R China
5.[5]Fuda Canc Inst, Guangzhou, Guangdong, Peoples R China
6.[6]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gen Surg, Wuhan, Hubei, Peoples R China
推荐引用方式
GB/T 7714
Alnaggar, Mohammed[1,2,3],Lin, Mao[4,5],Mesmar, Adnan[6],et al. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome[J],2018,48(5):1882.
APA Alnaggar, Mohammed[1,2,3].,Lin, Mao[4,5].,Mesmar, Adnan[6].,Liang, Shuzhen[5,6].,Qaid, Ammar[3].,...&Yin, Zhinan[1,2].(2018).Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.,48(5),1882.
MLA Alnaggar, Mohammed[1,2,3],et al."Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome".48.5(2018):1882.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace